PS36: When Stakeholders Want Digital Twins: Say Yes, Say No, or 'Not That Simple' ? - A Senior Leaders' Perspective (sponsored by BSLC)

As AI advances continue to reshape industries-from manufacturing to autonomous driving-the language of "digital twins", "simulation", and "AI-augmented decision-making" is increasingly entering conversations within pharma and biotech. Stakeholders across R&D, clinical development, and portfolio strategy are beginning to ask: Can we build digital twins for patients? Can we simulate trials end-to-end? And if other industries are doing it, why aren't we? This panel will convene 4 senior leaders from across the pharmaceutical industry to explore how decision-makers evaluate and respond to these high-pressure, high-visibility requests. Through a candid discussion, leaders will share how they balance innovation with scientific rigor and how they navigate the tension between emerging AI possibilities and the realities of regulatory, clinical, and data constraints. This session is sponsored by by the Biopharma Statistics Leadership Consortium (BSLC). BSLC is a collective of senior biopharmaceutical statistics leaders dedicated to improving patient outcomes through strategic collaboration.